GlaxoSmithKline PLC Director/PDMR Shareholding

Data : 15/01/2020 @ 08:00
Fonte : UK Regulatory (RNS & others)
Titolo : Glaxosmithkline Plc (GSK)
Quotazione : 1658.2  8.2 (0.50%) @ 17:35
Quotazione Glaxosmithkline Grafico

GlaxoSmithKline PLC Director/PDMR Shareholding

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico

2 Mesi : Da Dic 2019 a Feb 2020

Clicca qui per i Grafici di Glaxosmithkline

TIDMGSK

RNS Number : 8051Z

GlaxoSmithKline PLC

14 January 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  195 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  195 
                                              ==========================  ====================== 
                                              GBP17.9020                  684 
                                              ==========================  ====================== 
                                              GBP17.9020                  680 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 1,754 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr R Connor 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  101 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  101 
                                              ==========================  ====================== 
                                              GBP17.9020                  144 
                                              ==========================  ====================== 
                                              GBP17.9020                  178 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 524 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr N Hirons 
====  ======================================  ==================================================== 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  64 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  64 
                                              ==========================  ====================== 
                                              GBP17.9020                  75 
                                              ==========================  ====================== 
                                              GBP17.9020                  74 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 277 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr L Miels 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  137 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  190 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 327 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr D Redfern 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  80 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  80 
                                              ==========================  ====================== 
                                              GBP17.9020                  140 
                                              ==========================  ====================== 
                                              GBP17.9020                  168 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 468 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Mr R Simard 
====  ======================================  ====================================================== 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ====================== 
   GBP17.9020                                                               61 
   =======================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ====================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr P Thomson 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 9 January 2020 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan. 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP17.9020                  76 
 ===========================================  ==========================  ====================== 
                                              GBP17.9020                  95 
                                              ==========================  ====================== 
                                              GBP17.9020                  98 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 269 
==== 
  Aggregated volume                           GBP17.9020 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2020-01-13 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                     Mr B McNamara 
====  ========================================  =================================================== 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  =================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  =================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  =================================================== 
 b)    Nature of the                            Increase in notional interest in ADSs following 
        transaction                              the re-investment of dividends paid to 
                                                 shareholders on 9 January 2020 on ADSs 
                                                 held in the Company's Deferred Annual Bonus 
                                                 Plan. 
====  ========================================  =================================================== 
 c)    Price(s) and                             Price(s)                Volume(s) 
        volume(s) 
====  ----------------------------------------  ======================  ========================= 
                                                $46.6500                74 
 ---------------------------------------------  ======================  ========================= 
                                                $46.6500                72 
                                                ======================  ========================= 
                                                $46.6500                68 
                                                ----------------------  ------------------------- 
 
 
 d)    Aggregated information                   214 
==== 
  Aggregated volume                             $46.6500 
   Price 
 =============================================  =================================================== 
 e)    Date of the transaction                  2020-01-13 
====  ========================================  =================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Dr H Barron 
====  ========================================  ==================================================== 
 b)    Position/status                          Chief Scientific Officer and President, 
                                                 R&D 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Increase in notional interest in ADSs following 
        transaction                              the re-investment of dividends paid to 
                                                 shareholders on 9 January 2020 on ADSs 
                                                 held in the Company's Deferred Annual Bonus 
                                                 Plan. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.6500                406 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-13 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr J Ford 
====  ========================================  ==================================================== 
 b)    Position/status                          Senior Vice President and General Counsel 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Increase in notional interest in ADSs following 
        transaction                              the re-investment of dividends paid to 
                                                 shareholders on 9 January 2020 on ADSs 
                                                 held in the Company's Deferred Annual Bonus 
                                                 Plan. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.6500                35 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-13 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                     Ms K Terrell 
====  ========================================  =================================================== 
 b)    Position/status                          Chief Digital & Technology Officer 
====  ========================================  =================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  =================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  =================================================== 
 b)    Nature of the                            Increase in notional interest in ADSs following 
        transaction                              the re-investment of dividends paid to 
                                                 shareholders on 9 January 2020 on ADSs 
                                                 held in the Company's Deferred Annual Bonus 
                                                 Plan. 
====  ========================================  =================================================== 
 c)    Price(s) and                             Price(s)                Volume(s) 
        volume(s) 
====  ========================================  ======================  ========================= 
                                                $46.6500                24 
 =============================================  ======================  ========================= 
                                                $46.6500                86 
                                                ======================  ========================= 
 
 d)    Aggregated information                   110 
==== 
  Aggregated volume                             $46.6500 
   Price 
 =============================================  =================================================== 
 e)    Date of the transaction                  2020-01-13 
====  ========================================  =================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  =================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHVZLFFBFLXBBE

(END) Dow Jones Newswires

January 15, 2020 02:00 ET (07:00 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200223 11:56:35